Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $941.29M | $752.16M | $544.14M | $431.61M |
| Net Income | $267.43M | $207.36M | $18.00M | -$64.53M |
| EPS Diluted | $1.03 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $0.80 |
| $0.07 |
| -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.